StockWatch
·
HomeLiveWeekly

SHILPA MEDICARE LTD.

BSE: 530549

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-36.0953.29142.67232.05Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-14.867.2629.3851.50Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue201.11+21.4%165.70+22.8%134.93+46.0%92.43-26.7%126.15+0.6%125.39-3.3%129.68
Other Income6.89-39.0%11.29-33.4%16.94-4.8%17.79+26.3%14.08-16.3%16.83-21.6%21.47
Total Income208.00+17.5%176.99+16.5%151.88+37.8%110.22-21.4%140.24-1.4%142.21-5.9%151.15
EXPENSES
Expenditure158.35+4.9%151.00+35.6%111.39+23.4%90.26-14.3%105.35-9.5%116.39+16.4%100.03
Tax7.05-10.2%7.85-3.0%8.10+236.9%-5.91-38.3%-4.28-146.4%9.21-54.3%20.16
PROFIT
PBT78.02+228.0%23.79-38.9%38.92+163.3%14.79+256.8%-9.43-137.2%25.33-50.0%50.65
Net Profit70.97+345.4%15.93-48.3%30.83+48.9%20.70+501.6%-5.15-132.0%16.12-47.1%30.49
KEY METRICS
OPM %43.84%+26.46pp17.38%-10.47pp27.85%+15.06pp12.79%+19.99pp-7.20%-3.16pp-4.04%-16.35pp12.31%
NPM %34.12%+25.12pp9.00%-11.30pp20.30%+1.52pp18.78%+22.46pp-3.68%-15.02pp11.34%-8.83pp20.17%
EPS3.63+332.1%0.84-46.8%1.58-25.5%2.12+300.0%0.53-67.9%1.65-47.1%3.12

Corporate Events

BonusSHILPAMED
2025
3Oct

1:1

BSE Filing ↗
BonusSHILPAMED
2025
26Sep

1:1

BSE Filing ↗
Board MeetingSHILPAMED
2025
23Sep

Board Meeting

Ordinary Business: 1. Receive, consider and adopt the audite…

BSE Filing ↗
Board MeetingSHILPAMED
2024
13Nov

Board Meeting

Consider The Un-Audited Standalone and Consolidated Financia…

BSE Filing ↗
Board MeetingSHILPAMED
2024
23May

Board Meeting

Approval of the Audited Standalone and Consolidated Financia…

BSE Filing ↗
Board MeetingSHILPAMED
2024
8Feb

Board Meeting

Consider and approve raising of funds

BSE Filing ↗
Board MeetingSHILPAMED
2023
10Nov

Board Meeting

Consider and approve Un-audited financial results for the qu…

BSE Filing ↗
Board MeetingSHILPAMED
2023
10Aug

Board Meeting

Consider and approve the Un-audited Standalone and Consolida…

BSE Filing ↗